Johnson Probes FDA's Rare Disease Treatment Rejections
US News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Wisconsin Senator Ron Johnson is investigating the FDAs rejections of experimental treatments for rare diseases, focusing on complete response letters. Patient advocates and biotech firms criticize the agency for adding years and costs, while the FDA defends its decisions based on solid science. Johnson, a proponent of the Right to Try law, sees a pattern of shifting rules, highlighting the tension between patient urgency and regulatory caution.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/a132fa21cf6ae75b